File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Inarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response

TitleInarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response
Authors
Yuen, RMFElkhashab, MChen, CYChen, YFCoffin, CSFung, SKGreenbloom, SJang, JWJeng, WJKim, DJKim, YJKim, WLee, KSLim, YSLiu, CJRamji, AIyer, RMacfarlane, CJackson, KLocarnini, SAfdhal, NHChan, HLYACHIEVE STUDY Investigators,
Issue Date2018
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation
The American Association for the Study of Liver Diseases (AASLD): The Liver Meeting, San Francisco, USA, 9-13 November 2018. Abstracts in Hepatology, 2018, v. 68 n. 1, Suppl., p. 48A How to Cite?
DescriptionOral Abstract no. 75
Persistent Identifierhttp://hdl.handle.net/10722/275327
ISSN
0270-9139
2021 Impact Factor: 17.298
2020 SCImago Journal Rankings: 5.488

 

DC FieldValueLanguage
dc.contributor.authorYuen, RMF-
dc.contributor.authorElkhashab, M-
dc.contributor.authorChen, CY-
dc.contributor.authorChen, YF-
dc.contributor.authorCoffin, CS-
dc.contributor.authorFung, SK-
dc.contributor.authorGreenbloom, S-
dc.contributor.authorJang, JW-
dc.contributor.authorJeng, WJ-
dc.contributor.authorKim, DJ-
dc.contributor.authorKim, YJ-
dc.contributor.authorKim, W-
dc.contributor.authorLee, KS-
dc.contributor.authorLim, YS-
dc.contributor.authorLiu, CJ-
dc.contributor.authorRamji, A-
dc.contributor.authorIyer, R-
dc.contributor.authorMacfarlane, C-
dc.contributor.authorJackson, K-
dc.contributor.authorLocarnini, S-
dc.contributor.authorAfdhal, NH-
dc.contributor.authorChan, HLY-
dc.contributor.authorACHIEVE STUDY Investigators,-
dc.date.accessioned2019-09-10T02:40:19Z-
dc.date.available2019-09-10T02:40:19Z-
dc.date.issued2018-
dc.identifier.citationThe American Association for the Study of Liver Diseases (AASLD): The Liver Meeting, San Francisco, USA, 9-13 November 2018. Abstracts in Hepatology, 2018, v. 68 n. 1, Suppl., p. 48A-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/10722/275327-
dc.descriptionOral Abstract no. 75-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/-
dc.relation.ispartofHepatology-
dc.relation.ispartofAASLD (American Association for the Study of Liver Diseases): The Liver Meeting, 2018-
dc.titleInarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros304556-
dc.identifier.volume68-
dc.identifier.issue1, Suppl.-
dc.identifier.spage48A-
dc.identifier.epage48A-
dc.publisher.placeUnited States-
dc.identifier.issnl0270-9139-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats